LIDE provides a one-stop solution with various immune-oncology platforms to support an all-around biologics R&D in immunotherapy.
| Humanized Models > huPBMC reconstitution > huPBMC/cancer co-inoculation |
|
Syngeneic Models > Murine Syngeneic > Humanized Syngeneic |
|
| Mφ involved assay | In vitro assay using fresh samples from patients | ||
| DCs involved assay | CAR-T in vivo assay | ||
| NK cells involved assay | Oncolytic virus in vivo/in vitro assay | ||
